Reunion Neuroscience Inc. Common Shares
REUN
REUN was delisted on the 31st of July, 2023.
0 hedge funds and large institutions have $0 invested in Reunion Neuroscience Inc. Common Shares in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 21 closing their positions.
100% less funds holding
Funds holding: 21 → 0 (-21)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $1.94M → $0 (-$1.94M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 21
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$777K |
| 2 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
-$512K |
| 3 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
-$307K |
| 4 |
CM
Crystalline Management
Montreal, Quebec,
Canada
|
-$171K |
| 5 |
OPOWM
One Plus One Wealth Management
Jupiter,
Florida
|
-$85.9K |
REUN Hedge Fund Activity: Q3 2023 in Review
0 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Reunion Neuroscience Inc. Common Shares (REUN) for Q3 2023, worth a combined $0 — down 100% from $1.94M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of REUN and 0 opened new positions — a net loss of 21 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Beryl Capital Management, exiting entirely with an estimated $777K sold.
- 0 institutional investors held Reunion Neuroscience Inc. Common Shares (REUN) as of Q3 2023, down from 21 in Q2 2023.
- Funds reported $0 of Reunion Neuroscience Inc. Common Shares stock for Q3 2023, down 100% quarter-over-quarter.
- 0 funds opened new Reunion Neuroscience Inc. Common Shares positions in Q3 2023 and 21 closed out, a net change of -21 holders.
- The largest Reunion Neuroscience Inc. Common Shares seller in Q3 2023 was Beryl Capital Management, an estimated $777K sold.
Based on aggregated 13F filings for Q3 2023.